Theraclion S.A.
TCLIF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -0.00 | -0.00 | 0.00 |
| FCF Yield | 0.00% | -19,156.52% | -21,464.43% | 0.00% |
| EV / EBITDA | 0.00 | 0.99 | 0.82 | 3.60 |
| Quality | ||||
| ROIC | 0.00% | -32.06% | -22.32% | 0.02% |
| Gross Margin | -353.48% | -377.71% | -708.37% | -49.28% |
| Cash Conversion Ratio | 0.52 | 0.64 | 0.88 | 0.58 |
| Growth | ||||
| Revenue 3-Year CAGR | -1.13% | -1.88% | -7.84% | -13.53% |
| Free Cash Flow Growth | 0.00% | 6.23% | 0.00% | 100.00% |
| Safety | ||||
| Net Debt / EBITDA | 0.00 | 0.99 | 0.82 | 3.60 |
| Interest Coverage | -20.40 | 46.34 | -37.18 | -0.78 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 2.09 | 1.13 | 0.43 |
| Cash Conversion Cycle | 0.00 | 51.31 | 678.76 | 611.44 |